Ground-breaking neonatal CPAP device that leverages advances in medical research and sensor technology to provide superior respiratory support while lessening the burden on already thinly-stretched NICU nursing staff.
Initial design based off adult and existing neonatal CPAP devices, but enhanced to include key user-identified, context-specific feature sets.
Initial design based off adult and existing neonatal CPAP devices, but enhanced to include key user-identified, context-specific feature sets.SEE LESS
Stage 3: Proof of Concept
We have done 2 years of R&D, and have presented prototype for field testing/feedback to key opinion leaders in the implementation countries. We are proceeding with human factors/usability studies, along with planning for a clinical pilot.
Registered in United Statesin United States
Maternal Newborn and Child Health, Medical Devices and Social Development
Maternal Newborn and Child Health, Medical Devices and Social DevelopmentSEE LESS
Kenya, India, Rwanda and 1 MoreSEE ALL
Kenya, India, Rwanda and UgandaSEE LESS
Countries Implemented In
Funds Raised to Date
Respiratory distress (RD)/Respiratory Distress Syndrome (RDS) in newborns is characterized as difficulty in breathing and poor oxygen saturation, and has a mortality rate of nearly 100% without treatment. RDS is most common in premature infants; roughly 3.2 million globally are thought to suffer from RD that CPAP (Continuous Positive Airway Pressure) could treat. The mortality rate is only 2% with appropriate treatment, but is up to 75% in low-income countries with poor health outcomes.
We aim to provide a viable solution for reducing respiratory distress (RD)/respiratory distress syndrome (RDS) infant mortality in the form of an improved, user-centric neonatal CPAP device. Our CPAP will provide therapy that meets or exceeds global standards and will aid overburdened nurses in their mission to minimize interruptions to the critical life-saving therapy.
Newborns especially in low-resource settings.
Mission and Vision
Bridge the quality healthcare gap that exists globally by preventing newborn deaths and averting Disability Adjusted Life Years (DALYs).
• A built-in humidifier with the ability to swap out for an external humidifier
• Ability to use most consumables available on the market
• Internal air/O2 blending capability, with direct FiO2 adjustment and display
• A smart user-centric alarm system
• A portable size
Planned Goals and Milestones
• Human factors/usability studies in India and East Africa
• Manufacturing Qualification
• Clinical Pilot in India and East Africa
The Team Behind the Innovation
Our CEO, Krista Donaldson, has driven innovation in product design, engineering, and international development for more than 15 years, and she won acclaim as one of Fast Company’s 50 Designers Shaping the Future and a World Economic Forum Technology Pioneer. Our VP of Product Development, Ankur Garg, brings over 20 years of medical device, pharmaceutical and global health experience and she has successfully led a wide array of life-saving medical technologies from concept to commercialization.
EXECUTIVE TEAM INCLUDES WOMEN